Calumeo Aims to Make PPE Shortages a Thing of the Past With Practical Disinfecting Device

If there was one “most valuable player” that everyone in medical settings relied on during the pandemic, many would name personal protective equipment (PPE). However, while the lack of proper equipment has been felt acutely in every facility, the problem is not yet solved six months into COVID-19, with experts predicting that shortages could persist for years to come.

iDentical Raises $3.6 Million With its Novel Technology Designed to Address Dental Pain Point

COVID-19 might have temporarily closed dentist offices, but that hasn’t stopped iDentical from raising a healthy amount of cash for its innovative alternative to traditional dental implants.

Fogarty Institute company-in-residence iDentical has developed drill-free, non-invasive dental implants that leverage the latest 3D technology, with the goal of making tooth replacement safer,

Incubators Overcome Challenges, Point To Bright Future

If there’s one thing that incubators know how to do, it’s innovate. Therefore, it should come as no surprise that while the global pandemic provided challenges for everyone in every industry, incubators were able to find creative ways to survive and thrive.

A recent panel presentation brought together a number of speakers associated with all aspects of the incubator ecosystem,

Spirair Advances Office-Based Solution to Widespread Nasal Issue During Biodesign Summer Extension Program

Good ideas can come from anywhere, but as the Fogarty Institute has found over and over, the Stanford Biodesign Summer Extension program is a rich source for innovation. That’s why it has partnered with Stanford Biodesign to give promising projects even more hands-on expertise, including one-on-one and group mentoring, recommendations specialized to the company’s unique needs,

Fogarty Institute Helps Advance Promising Projects from Stanford Biodesign

For several years, the Fogarty Institute has partnered with Stanford Biodesign’s Summer Extension program, which provides funding to help advance promising projects. The Institute offers these young companies its signature hands-on mentoring from each member of the executive team, in addition to a dedicated mentor, along with a comprehensive development plan and opportunity to participate in educational workshops tailored to their specific needs.

Q&A with Denise Zarins, Fogarty Institute’s Chief Technical Officer

As we look ahead to the eventual easing of shelter-in-place requirements, companies are considering how to tackle the next phase of re-entry. Recently, we had the pleasure of hearing from Denise Zarins, Zach Edmonds, MD, and Gayle Kuokka, the dedicated re-entry leads for the Fogarty Institute, who held a collaborative discussion with our companies-in-residence and outside healthtech startups.

Commercialization and Reimbursement are Topics of the Fogarty Institute’s First Virtual Workshop

To effectively introduce a new product to market and ensure it is widely adopted, medtech companies must consider the many facets of their go-to-market strategy from the earliest days of product development.

This was the message of the Fogarty Institute’s third-annual educational workshop focused on commercialization. The three-part seminar series, being presented virtually to adhere to COVID restrictions,

Raydiant Oximetry Executive Team Spearheads the Launch of Ventilator Company Respirana

When Neil Ray, MD, founder and CEO of FII graduate Raydiant Oximetry and a board-certified anesthesiologist, learned about the global shortage of ventilators early in the COVID-19 crisis, he immediately considered ways that he, his colleagues and others in the Silicon Valley medtech ecosystem could help.

He first reached out to Russ DeLonzor,

Q&A with Mark Leahey, MDMA CEO and Fogarty Institute Board Member

As the Medical Device Manufacturers Association (MDMA) continues to take the lead in representing the interest of medtech companies, we wanted to sit down and talk with president and CEO, and Fogarty Institute board member, Mark Leahey, about the current landscape. MDMA is an incredibly nimble and effective organization – just like its constituents – and has been a beacon during the COVID-19 crisis,

START TYPING AND PRESS ENTER TO SEARCH